Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 35 > >>
EC Number Inhibitors Commentary Structure
Show all pathways known for 6.3.4.14Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.142-amino-N,N-dibenzyl-1,3-oxazole-5-carboxamide minimal inhibitory concentration above 64 microg per ml for wild-type, 16 microg per ml for mutant with targeted knock-out of efflux pump tolC and imp gene disruption Go to the Ligand Summary Page
Show all pathways known for 6.3.4.14Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.142-amino-N,N-dibenzyl-1,3-oxazole-5-carboxamide minimal inhibitory concentration above 64 microg per ml for wild-type, 4 microg per ml for mutant with targeted knock-out of efflux pump acrA Go to the Ligand Summary Page
Show all pathways known for 6.3.4.14Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.142-amino-N,N-dibenzyl-1,3-oxazole-5-carboxamide minimal inhibitory concentration 8 microg per ml for wild-type, 4 microg per ml for mutant with targeted knock-out of efflux pump acrA Go to the Ligand Summary Page
Show all pathways known for 6.3.4.14Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.142-amino-N-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-N-(2-methylbenzyl)-1,3-oxazole-5-carboxamide minimal inhibitory concentration above 64 microg per ml for wild-type, 8 microg per ml for mutant with targeted knock-out of efflux pump tolC and imp gene disruption Go to the Ligand Summary Page
Show all pathways known for 6.3.4.14Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.142-amino-N-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-N-(2-methylbenzyl)-1,3-oxazole-5-carboxamide minimal inhibitory concentration above 64 microg per ml for wild-type, 4 microg per ml for mutant with targeted knock-out of efflux pump acrA Go to the Ligand Summary Page
Show all pathways known for 6.3.4.14Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.142-amino-N-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-N-(2-methylbenzyl)-1,3-oxazole-5-carboxamide minimal inhibitory concentration 16 microg per ml for wild-type, 4 microg per ml for mutant with targeted knock-out of efflux pump acrA Go to the Ligand Summary Page
Show all pathways known for 6.3.4.14Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.142-Pyridyl disulfide - Go to the Ligand Summary Page
Show all pathways known for 6.3.4.14Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.146-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine minimal inhibitory concentration 16 microg per ml for wild-type, 0.125 microg per ml for mutant with targeted knock-out of efflux pump tolC and imp gene disruption Go to the Ligand Summary Page
Show all pathways known for 6.3.4.14Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.146-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine minimal inhibitory concentration 0.125 microg per ml for wild-type, 0.125 microg per ml for mutant with targeted knock-out of efflux pump acrA Go to the Ligand Summary Page
Show all pathways known for 6.3.4.14Display the word mapDisplay the reaction diagram Show all sequences 6.3.4.146-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine minimal inhibitory concentration 1 microg per ml for wild-type, 0.5 microg per ml for mutant with targeted knock-out of efflux pump acrA Go to the Ligand Summary Page
Results 1 - 10 of 35 > >>